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Abstract
Previous studies have shown that let-7 can repress the post-transcriptional translation of LIN28, and LIN28 in turn could
block the maturation of let-7, forming a double-negative feedback loop. In this study, we investigated the effect of germline
genetic variants on regulation of the homeostasis of the let-7/LIN28 loop and breast cancer risk. We initially demonstrated
that the T/C variants of rs3811463, a single nucleotide polymorphism (SNP) located near the let-7 binding site in LIN28,
could lead to differential regulation of LIN28 by let-7. Specifically, the C allele of rs3811463 weakened let-7–induced
repression of LIN28 mRNA, resulting in increased production of LIN28 protein, which could in turn down-regulate the level
of mature let-7. This effect was then validated at the tissue level in that the normal breast tissue of individuals with the
rs3811463-TC genotype expressed significantly lower levels of let-7 and higher levels of LIN28 protein than those individuals
with the rs3811463-TT genotype. Because previous in vitro and ex vivo experiments have consistently suggested that LIN28
could promote cellular transformation, we then systematically evaluated the relationship between rs3811463 as well as
other common LIN28 SNPs and the risk of breast cancer in a stepwise manner. The first hospital-based association study
(n=2,300) demonstrated that two SNPs were significantly associated with breast cancer risk, one of which was rs3811463,
while the other was rs6697410. The C allele of the rs3811463 SNP corresponded to an increased risk of breast cancer with an
odds ratio (OR) of 1.25 (P=0.0091), which was successfully replicated in a second independent study (n=1,156) with
community-based controls. The combined P-value of the two studies was 8.0610
25. Taken together, our study
demonstrates that host genetic variants could disturb the regulation of the let-7/LIN28 double-negative feedback loop and
alter breast cancer risk.
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Introduction
MicroRNAs (miRNAs) are an abundant class of ,22
nucleotides (nt) long endogenous noncoding RNAs that can guide
post-transcriptional gene silencing. They have important roles in
multiple physiological processes, including developmental timing,
cellular proliferation, differentiation, and apoptosis [1]. Deregu-
lation of miRNAs has been linked with the occurrence,
development, and prognosis of human cancers [2].
Let-7 is a family of miRNAs that were initially identified to
control heterochronic timing in the nematode Caenorhabditis elegans
[3]. Defects in let-7 in C. elegans result in unfavorable phenotypes,
such as over-proliferation and lack of terminal differentiation,
which resemble the characteristics of carcinogenesis in human
beings. Subsequent studies revealed that let-7 could regulate
multiple oncogenes, such as RAS [4], MYC [4,5], and HMGA2
[6]. A recent study has further linked abnormal let-7 levels to the
carcinogenesis of breast cancer and maintenance of malignant
phenotypes [7]. Based on these findings, let-7 is currently
recognized as a type of tumor suppressor miRNA. LIN28, which
was also initially discovered in C. elegans as a heterochronic gene
[8], has been identified as a reprogramming factor that can induce
pluripotent stem cells [9]. Overexpression of LIN28 promotes
cellular transformation and is associated with advanced human
cancers [10]. Taken together, these findings imply that LIN28
possesses oncogenic characteristics. Intriguingly, there is a double-
negative feedback loop between LIN28 and let-7; let-7 targets and
represses the translation of LIN28 [11,12], while LIN28 blocks the
maturation of let-7 miRNAs [13–16]. This cascade has recently
been demonstrated to be involved in the oncogenesis of human
cancers [17,18]. It is therefore of critical importance that the let-7/
LIN28 double-negative feedback loop is subjected to strict
regulation to stay at an appropriate homeostatic status. Although
detailed mechanisms of how this loop is regulated remain largely
unknown, it can be deduced that slight changes in let-7 or LIN28
levels can be amplified by the loop, resulting in more significant
alterations. Theoretically, physiological variations in let-7 and
LIN28 levels are also subjected to the amplifying effect of the loop,
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in different individuals.
One important source of inter-individual variation in pheno-
types is genetic variants, the major component of which is the
single nucleotide polymorphism (SNP). Many studies have shown
that allelic variants of SNPs can influence the expression and/or
function of their hosting genes. Several recent studies have further
highlighted that the miRNA-related SNPs, especially those located
within miRNA complementary sites, can remarkably alter the
biogenesis and/or function of the corresponding miRNA [19–22].
Breast cancer is a common female malignancy, and the
occurrence of breast cancer is associated with both genetic and
environmental risk factors. Although previous studies have
identified a group of high penetrance susceptibility genes and loci
of breast cancer, such as BRCA1, BRCA2, and CHEK2 [23],
these genes could only explain a small part of the genetic risk of
breast cancer. In the past several years, SNPs have been widely
employed as a type of genetic marker to identify susceptibility
genes or loci of breast cancer. Using this strategy, many low
penetrance susceptibility genes of breast cancer have been
successfully identified.
These findings prompted us to investigate if there were any
SNPs located with the let-7 and LIN28 genes that could alter the
biogenesis and/or function of these two factors and whether such
genetic variants were associated with risk of developing breast
cancer.
Results
Common genetic variants with potential functional effect
in the let-7 and LIN28 genes
We began by using in silico means to identify genetic variants
located within the let-7 and LIN28 genes that had potential
functional effect. The 12 genes of let-7 family with their 59 and 39
flanking sequences of 100 bp long as well as the coding sequence
(CDS), promoter region, and 39 untranslated region (39 UTR) of
LIN28 gene were searched in SNP databases as described in the
Materials and Methods section. No common SNP that has minor
allele frequency (MAF) higher than 5% in Han Chinese was found
in the CDS of LIN28 and let-7 genes along with their flanking
sequences, indicating LIN28 and let-7 are evolutionally conserva-
tive. We identified a SNP, rs3811464, in the promoter region of
LIN28 that was 126 bp upstream of the transcriptional start site of
LIN28. Although the initial prediction result showed that the
minor allele of rs3811464 could lead to a loss of the binding site for
one transcriptional factor named Zinc finger protein with
Interaction Domain (ZID), a luciferase assay failed to confirm
such an effect (data not shown). On the other hand, in the 39 UTR
of LIN28, we found three common SNPs (rs4659441, rs3811463,
and rs6697410) among Han Chinese women. Because the 39
UTRs are the primary binding and targeting site of miRNAs and
recent studies have highlighted that allelic variants within the 39
UTR could interfere with miRNA function [19–22], we then
investigated whether these SNPs were located near the binding
sites of miRNAs targeting LIN28. The predicted results showed
that only rs3811463 was located near the target sites of several
miRNAs (Figure S1A). Surprisingly and interestingly, the nearest
miRNA target site to rs3811463 was that of let-7 and, more
importantly, this site was highly conserved across different
prediction software packages. Therefore, we were very interested
in whether allelic variants of rs3811463 could influence let-7-
related regulation of LIN28 expression.
Let-7 differentially regulates LIN28 mRNA with allelic
variants of rs3811463
By comparing the genomic locations of rs3811463 and the
binding site of let-7, we found that rs3811463 was located 81 bp
downstream of the binding site of let-7 in the 39 UTR of the LIN28
mRNA (Figure 1A). Because the mRNA secondary structure is
critical for mRNA-miRNA interactions [24], we first examined
whether genetic variants of rs3811463 could alter the local second
structure of the LIN28 mRNA based on the minimum free energy
(MFE). RNAfold, an online RNA secondary structure prediction
software, predicted that allelic variants of rs3811463 could alter
the local mRNA secondary structure including that of the let-7
binding site. The minimum free energy changed from
293.0 kcal/mmol to 290 kcal/mmol when the nucleotide at
the rs3811463 locus changed from U to C (Figure 1B).
A luciferase assay was then performed to determine if let-7 could
differentially regulate LIN28 mRNAs with different alleles of
rs3811463. To begin with, the baseline levels of the four
representative let-7 miRNAs (let-7a, c, d, and f) were evaluated in
six common cell lines. The results revealed that two breast cancer
cell lines, T47D and BT474, express relatively lower levels of let-7
compared with other breast cancer cell lines (Figure 1C).
Fragments of the 39 UTR of the human LIN28 with either a T
or C at the site of rs3811463 were then subcloned into the
psiCHECK2 vector, generating two reporter vectors named
psiCHECK2:rs3811463T and psiCHECK2:rs3811463C, respec-
tively (Figure S1B). Different luciferase vectors (psiCHECK2,
psiCHECK2:rs3811463T, or psiCHECK2:rs3811463C) were co-
transfected with the synthesized human let-7 mimics (let-7a, c, d,
and f) or miRNA negative control (mirNC) into T47D cells. The
dual luciferase assays demonstrated that artificial overexpression of
let-7 in T47D could lead to differential suppression of the luciferase
activity of psiCHECK2:rs3811463T and psiCHECK2:rs381
1463C; the psiCHECK2:rs3811463T showed significantly lower
scores of luciferase activity when compared with psi-
CHECK2:rs3811463C. However, even though we observed
significant differences between the luciferase signal expressed by
psiCHECK2:rs3811463T and psiCHECK2:rs3811463C, we
found that the luciferase activities of the psiCHECK2:rs3811463C
Author Summary
Genetic variants are the genetic basis of inter-individual
differences in susceptibility to common diseases like
cancer. Single nucleotide polymorphisms (SNPs) are the
major type of genetic variation in human beings, and
previous studies have linked many SNPs with the risk of
suffering human malignancies. In this study, we focused
on microRNA (miRNA)–related SNPs and their relationship
with the risk of breast cancer. MiRNAs are a kind of tiny
endogenous RNAs that play important regulatory roles.
Let-7 is a miRNA that has been proven to be capable of
inhibiting the tumor occurrence. LIN28, a gene that
promotes cancer, is a known regulator of let-7 and,
interestingly, LIN28 itself is subject to repression by let-7.
We have discovered that an SNP located near the target
site of let-7 in LIN28 disturbs let-7’s regulation of LIN28.
This disturbance eventually leads to an increased level of
LIN28 and a decreased level of let-7. We also, for the first
time, confirmed that this SNP is associated with an
increased risk of breast cancer in Han Chinese women.
Our results suggest that genetic variants may potentially
build a bridge from a physiological status to an aberrant,
even pathological, status with the let-7/LIN28 loop in
breast tissue, thus, facilitating carcinogenesis.
A LIN28 39 UTR SNP and Breast Cancer Risk
PLoS Genetics | www.plosgenetics.org 2 September 2011 | Volume 7 | Issue 9 | e1002259Figure 1. Let-7 differentially regulates allelic variants of rs3811463. A, schematic representation of the let-7 target site and the rs3811463
locus. A partial sequence of the 39 UTR of LIN28 is shown. The rs3811463 SNP is located 81 nucleotides (nt) downstream of the ‘‘seed complementary
sequence’’ of let-7 in LIN28. B, the predicted secondary structure of the LIN28 mRNA. The secondary structures of the 39 UTR of LIN28 were predicted
by inputting two 301-nt long DNA sequences centering rs3811463 into RNAfold, with either the rs3811463-T (left) or rs3811463-C (right) allele. The
figures and the values of minimum free energy (MFE) were generated by RNAfold (http://rna.tbi.univie.ac.at). C, levels of let-7 (let-7a, c, d, and f)i n
different cell lines. The level of let-7 was higher in HEK-293T cells than in several breast cancer cell lines, especially BT474 and T47D cells. D, luciferase
reporter assays. The assays were performed in T47D and HEK-293T cells, which express low and high levels of let-7, respectively. Luciferase assays
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7 mimics, especially let-7c mimics. (Figure 1D, top). To determine
whether let-7 could regulate psiCHECK2:rs3811463C and the
differential suppression of psiCHECK2:rs3811463T and psi-
CHECK2:rs3811463C was let-7 dependent, we replicated the
luciferase assay with increasing amounts of synthesized let-7c. The
results showed that the luciferase signal of the control psiCHECK2
vector was comparable in each group regardless of the doses of
transfected let-7c (data not shown). Both psiCHECK2:rs3811463T
and psiCHECK2:rs3811463C vectors, on the other hand, were
increasingly suppressed as the concentration of the let-7c mimics
increased while psiCHECK2:rs3811463T was more significantly
suppressed than psiCHECK2:rs3811463C (Figure 1D, middle).
The same trend was observed when we replicated the assay with
mounting amounts of synthesized let-7f (Figure S1C).
To further confirm that the differential suppression of
psiCHECK2 luciferase vectors containing different 39 UTRs of
LIN28 was the specific effect of let-7, we performed a let-7
inhibition assay. We first replicated the luciferase assay with
different psiCHECK2 vectors and let-7 mimics in HEK-293T
cells. As indicated in Figure 1C, HEK-293T cell expresses a high
level of endogenous let-7, which was reflected by the luciferase
assay in that the luciferase activity of psiCHECK2:rs3811463T
and psiCHECK2:rs3811463C showed a significant difference
even when the cells were transfected with the negative control of
miRNA mimic (mirNC) (Figure 1D, bottom). We then inhibited
endogenous let-7 (let-7c and let-7d) in HEK-293T cells using specific
let-7 inhibitors, the effects of which were confirmed by Taqman
real-time PCR (Figure S1D). The luciferase assay showed that a
reduction in the concentration of endogenous let-7 in HEK-293T
cells was able to abolish the differences in the luciferase activity of
these two vectors compared with the baseline condition (Figure 1D,
bottom), confirming that the differential regulation of psi-
CHECK2:rs3811463T and psiCHECK2:rs3811463C is the
specific function of let-7.
These experiments showed that let-7 could suppress expression
of the luciferase gene by targeting the 39 UTR of LIN28 and that
the suppressing effect of let-7 could be weakened when the
nucleotide at the rs3811463 locus changed from the ancestral T to
the variant C. This discovery indicated that T/C variants of
rs3811463 could lead to differential regulation of the LIN28
mRNA by let-7 miRNAs.
LIN28 negatively regulates let-7 in breast cancer cell lines
Although previous studies have shown that LIN28 could
negatively regulate let-7, it remains unknown whether this is the
same case in the molecular context of breast cancer. To address
this question, we arbitrarily overexpressed LIN28 in MCF7, SK-
BR-3, and MDA-MB-231 cells, which express relatively higher
levels of let-7 (Figure 1C), and evaluated the change in let-7 levels.
Because the luciferase assay revealed that let-7f could more
significantly repress LIN28 mRNA (Figure 1D, top), we took it as a
representative of other members of the let-7 family. Real-time
PCR revealed that overexpression of LIN28 (Figure 2A) could lead
to 30–60% lower levels of let-7f (P,0.05) (Figure 2B). To further
investigate whether the reduction in the level of let-7f was LIN28-
dependent, we infected SK-BR-3 and MCF7 cells with different
volumes of unconcentrated viral supernatant containing LIN28
expression vectors. Real-time PCR results showed that there was a
LIN28 dose-dependent reduction in the concentration of endog-
enous let-7f in SK-BR-3 and MCF7 cells (Figure 2C), proving that
LIN28 could inhibit the maturation of let-7 in the molecular
context of breast cancer cells.
Allelic variants of rs3811463 alter the levels of let-7, LIN28
mRNA, and LIN28 protein in normal breast tissue
Based on these findings, we proposed a biological model in
which the variant rs3811463-C allele, compared with the ancestral
rs3811463-T allele, can weaken the suppression of LIN28 mRNA
by let-7, leading to overexpression of LIN28 protein, which in turn
reduces the level of mature let-7 and eventually results in altered
status of the whole let-7/LIN28 loop.
To test this model, we randomly selected 300 patients who had
donated both peripheral blood and normal breast tissue and
determined their rs3811463 genotypes by RFLP-based assays.
From these patients, we selected 30 patients with TT genotypes
and 30 patients with TC genotypes. We did not include the
rs3811463-CC genotype due to the rareness of this genotype. The
included patients with the TT genotype were comparable to those
with the TC genotype in regard to the distribution of breast cancer
risk factors and the histological characteristics of their disease
(Table S1).
We then examined the levels of let-7f, LIN28 mRNA, and
LIN28 protein in the epithelial cells of the acquired normal breast
tissue. As shown in Figure 3A, a significantly lower level of let-7f
was observed in the normal breast tissue of individuals with the
TC genotype than in that of women with the TT genotype
(P=0.004). Although the LIN28 mRNA expression level was
higher in the tissue with the TC genotype than in those with the
TT genotype, the difference was not statistically significant
(P=0.81) (Figure 3B). However, the level of LIN28 protein was
significantly higher in the breast tissue with the TC genotype than
that with the TT genotype (P=0.028) (Figure 3C). Furthermore,
lower levels of let-7f generally corresponded to higher levels of
LIN28 protein (Figure 3D), suggesting that let-7 regulate LIN28
mainly through inhibiting the translation, rather than through
inducing the degradation, of LIN28 mRNA.
Taking all these findings together, the rs3811463-C allele is
correlated with a high level of LIN28 protein and a low level of let-7
in a normal physiological context, which is consistent with our
model.
Two SNPs in LIN28, rs3811463 and rs6697410, are
associated with breast cancer in the first case-control
study
Our results thus far indicated that genetic variants in let-7 and
LIN28 genes, such as rs3811463, might potentially alter the levels
of the let-7/LIN28 loop in individuals with different genetic
backgrounds. Because the increased LIN28 levels and decreased
let-7 levels have been previously associated with carcinogenesis
performed in T47D cells shows that overexpression of let-7 can lead to differential suppression of the luciferase activity of psiCHECK2:rs3811463T and
psiCHECK2:rs3811463C (top). By transfecting T47D cells with different amounts of let-7c mimics, we show that the differential suppression of
psiCHECK2:rs3811463T and psiCHECK2:rs3811463C is in a let-7 dose-dependent manner (middle). Compared with T47D cells, HEK-293T cells express
relatively higher levels of let-7. This is why even when no let-7 mimic is transfected into the cells (mirNC group), there are significant differences in the
luciferase signal expressed by psiCHECK:rs3811463T and psiCHECK:rs3811463C (bottom, left groups). The let-7 inhibition assay shows that inhibition
of the endogenous let-7 in HEK-293T cells is able to abolish the differences in the luciferase activity of psiCHECK2:rs3811463T and
psiCHECK2:rs3811463C (bottom, right groups).
doi:10.1371/journal.pgen.1002259.g001
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especially rs3811463, were associated with the risk of breast
cancer. Because an initial study failed to identify any common
SNPs in let-7 genes, we conducted association studies to investigate
the relationship between common SNPs in the LIN28 gene
(including rs3811463) and the risk of breast cancer at the
molecular epidemiological level. The included SNPs were selected
as described in the Materials and Methods section.
In the first hospital-based case-control study, we evaluated the
frequency distribution of the selected SNPs in 1,004 cases and
1,296 controls. All genotyped SNPs had a minor allele frequency
(MAF) greater than 9% (Table 1). Based on a threshold of 0.05, no
significant deviation from Hardy-Weinberg Equilibrium (HWE)
was found in the control group. As shown in Table 1, we found
that two SNPs located within the 39 UTR of LIN28 were
significantly associated with breast cancer. Encouragingly, one of
these two SNPs was rs3811463 and another one was rs6697410.
The P-values continued to be significant after permutation tests or
Bonferroni correction using a threshold of 0.05. When compared
to the ancestral rs3811463-T allele, the rs3811463-C allele was
associated with an increased risk of breast cancer (odds ratio (OR),
1.25; 95% confidence interval (CI) 1.06–1.47; P=0.0091). In
contrast, the rs6697410-G allele was associated with a reduced risk
of breast cancer as compared to the ancestral rs6697410-T allele
(OR, 0.76; 95% CI 0.63–0.93; P=0.0068). The distribution of
genotypes among cases and controls in the test set is shown in
Table 2. Using the common homozygous genotypes as the
references, we found that the rs3811463-TC genotype correlated
with an increased risk of breast cancer while the rs6697410-TG
genotype was associated with a decreased risk of breast cancer.
However, significant associations between the homozygous
genotypes of variant alleles (rs3811463-CC and rs6697410-GG)
and the risk of breast cancer were not found, which might be due
to the rareness of these two genotypes in the population.
Validation of the test set results in a second case-control
study
To validate our findings in the test set, we performed another
independent case-control study involving 511 cases and 645
controls. Unlike the first study, all of the controls in the validation
Figure 2. LIN28 represses let-7 in the molecular context of breast cancer. A, overexpression of LIN28 protein in different breast cancer cell
lines. The left panel shows a representative Western blot detection of LIN28 protein in MCF-7, SK-BR-3, and MDA-MB-231 transfected with control or
LIN28 overexpression vectors, respectively. The right panel shows the quantified results of the Western blot assay. LIN28 is normalized to the loading
control GAPDH. B, upregulation of LIN28 downregulates mature let-7f levels. The panel shows the levels of let-7f in MCF7, SK-BR-3, and MDA-MB-231
cells transfected with either control vector or LIN28-expressing vector. Significantly lower levels of mature let-7f were detected in cells overexpressing
LIN28. C, the level of LIN28 is inversely correlated with let-7f. SK-BR-3 and MCF-7 cells were infected with increasing amounts of LIN28 vectors
(determined by the volumes of the viral supernatant). The let-7f levels were evaluated 48 h after infection. As shown in the graph, there was an
inverse dose-dependent relationship between LIN28 and let-7f levels.
doi:10.1371/journal.pgen.1002259.g002
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PLoS Genetics | www.plosgenetics.org 5 September 2011 | Volume 7 | Issue 9 | e1002259Figure 3. Differential expression of let-7f, LIN28 mRNA, and LIN28 protein in normal breast tissue of individuals with different
rs3811463 genotypes. A, real-time PCR analysis of let-7f levels in RNA samples extracted from normal breast tissue donated by individuals with the
rs3811463-TT genotype (n=30) or rs3811463-TC genotype (n=30). The horizontal lines represent the mean values. The mean let-7f levels in breast
tissue of the rs3811463-TT genotype were approximately 1.6 times higher than in the tissue of the rs3811463-TC genotype (Mann-Whitney U-test,
A LIN28 39 UTR SNP and Breast Cancer Risk
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breast cancer screening program as previously described [25]. In
this set, the results of the initial study were successfully replicated;
rs3811463-C allele was associated with an increased risk of breast
cancer, while rs6697410-G was associated with a reduced risk of
breast cancer. The associations were more significant when the
two studies were combined together; the P value for the
rs3811463-C allele was 8.0610
25, whereas it was 7.0610
24 for
the rs6697410-G allele. After adjusting for common breast cancer
risks, these two allelic variants were still significantly associated
with the risk of breast cancer (Table 3).
The distribution of rs3811463 genotypes among women
with different molecular subtypes of breast
cancer. Because a recent study revealed that let-7 could
regulate estrogen receptor (ER) alpha signaling [26], while our
study showed that genetic variants of rs3811463 could alter the
levels of let-7, we further evaluated the distribution of different
rs3811463 genotypes among the different molecular subtypes of
breast cancer. The breast cancer was divided into three subtypes
according to the status of ER, PR, and HER2, as described in the
Materials and Methods. There were 918 patients with IHC results
for the three markers and rs3811463 genotyping information
available. As shown in Table S2, the distribution of rs3811463
genotypes (TT versus TC+CC) in different breast cancer subtypes
were not significantly different (P=0.26).
LIN28 promotes transformation of a normal breast
epithelial cell line. Finally, we evaluated the ability of LIN28
to transform normal breast epithelial cells using the soft agar assay.
MCF 10A cells infected with control viral vector and MCF 10A
cells stably overexpressing LIN28 were cultured in soft agar
medium under the same conditions for 3 weeks. As shown in
Figure 4A, MCF 10A cells overexpressing LIN28 formed
significantly more colonies than the MCF 10A infected with
control vector (P=0.006). These results suggest that LIN28 could
promote the transformation of normal breast epithelial cells, which
is consistent with previous studies [10]. This result, combined with
the above-mentioned discovery that the rs3811463-C allele could
weaken let-7-related suppression of LIN28 protein expression and
lead to overexpression of LIN28, could in part explain the
relationship between the rs3811463-C allele and the risk of
developing breast cancer.
Discussion
In the current study, we for the first time confirmed that the C
allele of rs3811463, a SNP located near the binding site of let-7 in
LIN28, can weaken the suppression of LIN28 by let-7, disturb the
let-7/LIN28 double-negative feedback loop, and ultimately result
in an increased level of LIN28 protein and decreased level of let-7.
Population-based association studies further related the
rs3811463-C allele with an elevated risk of breast cancer.
Let-7 is comprised of a family of miRNAs that can target and
repress the translation of LIN28 mRNA into LIN28 protein
[11,12]. LIN28 protein, on the other hand, can block the
maturation of let-7 [11,13,15,16]. Thus, these two factors form a
unique double-negative feedback loop. Let-7 is a recognized tumor
suppressor [3], while LIN28 acts like an oncogene that can
promote cellular transformation [8,10]. Deregulation of both let-7
and LIN28 has been associated with tumorigenesis [7,10].
Accumulating evidence has also demonstrated that the let-7/
LIN28 loop can interact with other factors, such as RAS, MYC,
and NF-kB [17,18], to form a complex network associated with
carcinogenesis.
However, the mechanisms by which let-7/LIN28 loop
homeostasis is maintained and whether inter-individual differ-
ences in the levels of this loop are associated with the risk of
developing cancer, such as breast cancer, remain largely
unknown. The results of this study suggest that germline genetic
variants of LIN28, such as with rs3811463, may lead to altered
status of the let-7/LIN28 loop and are associated with breast
cancer susceptibility. As illustrated in Figure 4B, we define the
green region as the normal condition, in which the nucleotide at the
locus of rs3811463 is the ancestral T allele. Under this condition,
let-7 can sufficiently regulate LIN28, maintaining LIN28 protein
at a relatively low level. The replacement of the T allele by the
variant C allele, however, weakens the suppression of LIN28
mRNA by let-7, resulting in overexpression of LIN28 protein,
which can in turn reduce the level of let-7. With the amplifying
Table 1. Frequency of LIN28 alleles in breast cancer patients and controls in the test set.
SNP Position Risk allele Cases (n
{, %) Controls (n
{,% ) P
1 P
I
rs12122703(A.G) c.21645 A 1,711(85.9) 2,147(84.9) N.S. N.S.
rs3811464(G.A) c.2240 G 1,702(85.2) 2,116(83.8) N.S. N.S.
rs11247955(G.A) c.342+10135 G 1,783(90.2) 2,235(89.3) N.S. N.S.
rs3811463(T.C) c.*993 C 319(16.2) 341(13.4) 9.1610
23 0.045
rs6697410(T.G) c.*3260 T 1,731(90.6) 2,239(88.0) 6.8610
23 0.037
N.S., no significance. The significance of boldface is a P-value of ,0.05.
{Number of allele.
1Unadjusted P-value of two-sided x
2 test.
IP value after 1,000-permutation tests.
doi:10.1371/journal.pgen.1002259.t001
P-value=0.004). B, real-time PCR analysis of LIN28 mRNA in the same batch of RNA samples. The horizontal lines represent the mean values. The
mean LIN28 mRNA levels in the two groups were not significantly different (Mann-Whitney U-test, P-value=0.81). C, LIN28 protein levels were
investigated in the corresponding tissue with immunohistochemistry (IHC). The rs3811463-TC genotype was associated with increased levels of LIN28
protein as compared with the rs3811463-TT genotype (Cochran-Mantel-Haenszel x
2 test P-value=0.028). The graphs on the right show
representative IHC results. D, the relationship between let-7f levels and LIN28 protein expression levels in normal breast tissue. The graph depicts the
levels of let-7f and LIN28 protein (IHC score) for each individual. Generally, lower levels of let-7f correspond with higher levels of LIN28 protein.
doi:10.1371/journal.pgen.1002259.g003
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concentration of LIN28 protein will increase, while the level of
let-7 decreases until a new balance is achieved by mechanisms
that remain unknown (Figure 4B; red circle). Both the increased
level of LIN28 protein and reduced level of let-7 are associated
with carcinogenesis, which explains the relationship between the
rs3811463-C allele and an increased risk of breast cancer, as
shown by the case-control studies.
It should be noted that even though in this study we have
proven that genetic variants of rs3811463 could influence the
regulation of LIN28 by let-7, we cannot exclude the possibility that
they can also interfere with other regulatory mechanisms. The first
possibility is that genetic variants of rs3811463 can interfere the
functions of other miRNAs besides let-7, especially considering that
there are target sites for several other miRNAs near the binding
site of let-7 according to the target prediction results. This
Table 3. Validation of the two susceptibility SNPs located in LIN28 in the validation and combined sets.
SNP
Allele or
Genotype Validation set OR (95% CI) P Two sets combined OR (95% CI) P
Cases (n, %) Controls (n, %) Cases (n, %) Controls (n, %)
rs3811463 T 812* (82.7) 1,105* (87.4) Reference 2,463* (83.4) 3,304* (86.9) Reference
C 170* (17.3) 159* (12.6) 1.46 (1.51–1.84) 1.7610
23{ 489* (16.6) 500* (13.1) 1.31 (1.15–1.50) 8.0610
25{
TT 342 (69.7) 487 (77.1) Reference 1,035 (70.1) 1,438 (75.6) Reference
TC+CC 149 (30.3) 145 (22.9) 1.46 (1.12–1.91) 5.0610
23{ 441 (29.9) 464 (24.4) 1.32 (1.13–1.54) 6.6610
24{
1.44 (1.08–1.91) 0.01
{ 1.36 (1.15–1.61) 2.9610
24{
rs6697410 T 892* (90.3) 1,105* (87.6) Reference 2,623* (90.5) 3,344* (87.9) Reference
G 96* (9.7) 157* (12.4) 0.76 (0.58–0.99) 0.04
{ 275* (9.5) 460* (12.1) 0.76 (0.65–0.89) 7.0610
24{
TT 406 (82.2) 485 (76.9) Reference 1,191 (82.2) 1,474 (77.5) Reference
TG+GG 88 (17.8) 146 (23.1) 0.73 (0.54–1.00) 0.05
{ 258 (17.8) 428 (22.5) 0.75 (0.63–0.89) 1.0610
23{
0.69 (0.50–0.96) 0.03
{ 0.75 (0.62–0.90) 2.0610
23{
The significance of boldface is a P,0.05.
*Number of allele.
{Unadjusted P value of two-sided x
2 test.
{Adjusted for age and family history of breast cancer.
doi:10.1371/journal.pgen.1002259.t003
Table 2. Associations between LIN28 genotypes and breast cancer risk in the test set.
SNP Genotype Case (n) Control (n) OR (95% CI)
* OR (95% CI)
{ Dominant model OR (95% CI)
{,
{
Recessive model OR
(95% CI)
{,
{
rs12122703 AA 735 909 Reference Reference 1.00 (0.81–1.23) 1.29 (0.69–2.43)
AG 241 329 0.91 (0.75–1.10) 0.97 (0.78–1.21)
GG 20 26 0.95 (0.53–1.72) 1.28 (0.68–2.42)
rs3811464 GG 725 882 Reference Reference 0.83 (0.68–1.02) 0.86 (0.42–1.73)
GA 252 352 0.87 (0.72–1.05) 0.83 (0.67–1.03)
AA 22 28 0.96 (0.54–1.69) 0.81 (0.40–1.65)
rs11247955 GG 802 996 Reference Reference 1.01 (0.80–1.28) 0.99 (0.36–2.74)
GA 179 243 0.92 (0.74–1.13) 1.01 (0.80–1.29)
AA 7 13 0.67 (0.27–1.68) 1.00 (0.36–2.75)
rs3811463 TT 693 951 Reference Reference 1.35 (1.10–1.67) 1.20 (0.61–2.35)
TC 265 297 1.22 (1.00–1.47) 1.36 (1.09–1.69)
CC 27 22 1.55(0.87–2.78) 1.29(0.66–2.54)
rs6697410 TT 785 989 Reference Reference 0.75 (0.60–0.96) 0.51 (0.21–1.26)
TG 161 261 0.78 (0.63–0.97) 0.78 (0.61–0.99)
GG 9 21 0.54(0.25–1.19) 0.49(0.20–1.21)
The significance of boldface is a P-value of ,0.05.
*Unadjusted odds ratio (OR) and 95% confidential interval (CI) calculated by logistic regression.
{OR and 95% CI calculated by logistic regression, adjusted for age, age at menarche, menopause status, number of birth, body mass index (BMI) and family history of
breast cancer. Major genotype is indicated as reference.
{For the model, homozygotes for the major allele (1/1), heterozygotes (1/2), and homozygotes for the rare allele (2/2) are coded as a continuous numeric variable for
genotype (i.e. 0, 1, and 2). The dominant model is defined as contrasting genotypic groups 1/1 versus (1/2+2/2), and the recessive model is defined as contrasting
genotypic groups 2/2 versus (1/1+1/2).
doi:10.1371/journal.pgen.1002259.t002
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PLoS Genetics | www.plosgenetics.org 8 September 2011 | Volume 7 | Issue 9 | e1002259Figure 4. LIN28 transforms MCF 10A cells. A, LIN28 transforms MCF 10A cells. The upper left panel shows the Western blot analysis of protein
extracted from the control MCF 10A or the LIN28-overexpressing MCF 10A cells. The bottom left and right panels show the number of colonies
formed in the soft agar assay. Data shown represent mean colony numbers with error bars showing standard errors. MCF 10A cells stably
overexpressing LIN28 formed significantly more colonies than the MCF 10A cells infected with control viral supernatant (P=0.006). B, schematic
representation of the biological model. In this model, LIN28 harboring the rs3811463-T allele was set as the baseline condition (green loop).
Replacement of the T allele by the C allele at rs3811463 weaken the suppression of the LIN28 mRNA by let-7, leading to overexpression of LIN28
protein and, in turn, lower levels of let-7. Both high levels of LIN28 and low levels of let-7 are associated with carcinogenesis, as indicated in the
Introduction section.
doi:10.1371/journal.pgen.1002259.g004
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the luciferase activity of both psiCHECK2:rs3811463T and
psiCHECK2:rs3811463C were significantly lower than those of
the control psiCHECK2 vector even when no synthesized let-7
was transfected, and the concentration of endogenous let-7 is
relatively low in T47D cells. A second possible mechanism is that
the T/C variants of rs3811463 might alter the functional motif of
other regulatory factors apart from miRNAs, even though there is
currently insufficient evidence for this possibility. In addition, even
though we have demonstrated that T/C variants of rs3811463 can
lead to differential suppression of LIN28 mRNA by let-7, we are
still unclear about the precise mechanism of how these genetic
variants influence the function of let-7. Thus, more studies are
warranted to elucidate these questions.
The occurrence of human breast cancer is generally attributed
to both the genetic and environment risk factors. Much effort has
gone into identifying the genetic risk factors of breast cancer and
previous studies have found a group of high-penetrance suscep-
tibility genes for breast cancer, which are generally involved in
DNA repair pathways. Mutations in these genes are rare but have
significant effects [23]. However, these genes only account for a
small proportion of the genetic risk of breast cancer. It has become
increasingly evident that common low-penetrance genetic variants
may have a more prominent role [27]. SNPs are the most
common type of genetic variants in human genome [28]. They are
the genetic basis of the inter-individual variations in heritable
phenotypes, such as susceptibility to cancers. A number of SNPs
have been identified by previous studies to be associated with
breast cancers, many of which are located within the promoter or
CDS regions of genes [25,29]. Our study, on the other hand,
focused on miRNA-related SNPs. This study was part of a
research program that aimed to identify: 1) common SNPs located
within miRNA genes, miRNA target sites, and miRNA regulatory
genes; and 2) the relationships between these SNPs and the risk of
breast cancer. It was previously hypothesized that miRNA-related
genetic variants might alter the biogenesis and/or function of their
corresponding miRNAs [30,31]. This hypothesis has been
validated by multiple studies that found that SNPs located within
or near the target sites of miRNAs could influence the functions of
miRNAs and were associated with human cancers [19–21]. It
seems that this is a common mechanism [22]. In this study, we
demonstrate that the genetic variants of rs3811463, a SNP located
within the 39 UTR of LIN28, can weaken the suppression of
LIN28 by let-7 and is associated with the risk of breast cancer. Our
study and previous studies all suggest that miRNA-related SNPs,
especially those located near the complementary sites of miRNAs,
are a new source of human cancer susceptibility loci.
In the case-control studies, we also found that another SNP,
rs6697410, was associated with the risk of breast cancer. The
underlying mechanism is still to be elucidated. In silico analysis
showed that rs3811463 was located at the end of the 39 UTR of
LIN28, and there was no miRNA target site nearby. We propose
several possibilities. First, it is possible that other polymorphisms
linked with rs6697410 are responsible for this relationship, which
means that rs6697410 is a marker for another functional SNP
rather than a functional SNP by itself. Second, the nearby
sequence may contain target sites for certain miRNAs, but the
current in silico analysis tools failed to identify them. Third, genetic
variants of rs6697410 may exert their function by influencing
other function motifs involved in the regulation of LIN28 [32].
Further studies are needed to address this problem.
Finally, the focus of the current study is on the influence of
genetic variants on the phenotypic variations of the let-7/LIN28
loop and their impact on the risk of developing breast cancer
among women with different genetic backgrounds. We found that
the existence of the let-7/LIN28 double-negative feedback loop
might amplify even slight variations in the levels of let-7 and/or
LIN28, which could result in significant biological or even
pathological effects. Based on such a finding, we hypothesize that
other mechanisms that also change the levels of let-7 and/or
LIN28 are equally possible to induce the same effects. These
mechanisms may include an epigenetic switch, transcriptional
regulation, and so on. In addition, we are also aware of the
deficiencies inherent in the design of our study: the possibility that
we may miss genetic variants with low allele frequencies but
prominent function. Even though we have 95% power to identify
SNPs like rs3811463 (MAF=14.6% and OR=1.31), when we
combine the two studies together, the power to detect those with
MAF less than 10% drops dramatically to approximately 75%.
Thus, further investigations are warranted to fully evaluate the
effects of other possible mechanisms as well as the effects of the less
common SNPs in the LIN28 and let-7 genes.
Materials and Methods
Identification and in silico analysis of genetic variants
involving the let-7/LIN28 loop
The miRBase, the Gene and dbSNP databases of National
Center for Biotechnology Information (NCBI), and the Interna-
tional HapMap Project database were first employed to identify
SNPs located within the LIN28 and human let-7 genes that had
potential functional effect. The coding sequence (CDS), promoter
region (defined as the 2 Kb sequence upstream of the transcrip-
tional start site of LIN28), and 39 untranslated region (39 UTR) of
LIN28 were located using Gene database of NCBI. The genes of
human let-7 (hsa-let-7) were determined through data curated by
miRBase and confirmed through Gene database of NCBI.
Because the let-7 genes acquired from miRBase and NCBI
actually are those encode the precursors of let-7, we further
identified the 59 and 39 flanking sequences of 100 bp long of these
genes. SNPs located within the above-identified sequences were
searched in the dbSNP database of NCBI and International
HapMap Project database. The criteria for SNP selection was
based on: 1) minor allele frequency (MAF) higher than 5% in Han
Chinese in Beijing (CHB) according to HapMap database in order
to be appropriate for including in the following case-control
studies and 2) have potential functional effect based on the in silico
analyzing methods as listed below. TESS (http://www.cbil.upenn.
edu/cgi-bin/tess/tess) and TFSEARCH (http://www.cbrc.jp/
research/db/TFSEARCH.html) were used to analyze the binding
sites of the transcription factors. TargetScanHuman 5.1 (http://
www.targetscan.org/), PicTar (http://pictar.mdc-berlin.de/), and
MicroCosm Targets Version 5 (http://www.ebi.ac.uk/enright-
srv/microcosm/htdocs/targets/v5/) were employed to predict the
target sites of miRNAs. RNAfold software (http://rna.tbi.univie.
ac.at/) was used to calculate the secondary structure of RNA based
on minimum free energy (MFE).
Luciferase reporter assay
An 885-bp fragment of the 39 UTR of human LIN28 gene
centering rs3811463 and the predicted complementary site of let-7
was subcloned into the psiCHECK2 vector (Promega, Madison,
WI, USA) using the Xhol and NotI restriction sites located 39 to
the Renilla luciferase translational stop codon. A mutant plasmid
with C allele at the site of rs3811463 was constructed using a site-
directed mutagenesis kit (Stratagene, La Jolla, CA, USA). All
vectors were verified by direct sequencing. The generated reporter
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CHECK2:rs3811463C, respectively.
To conduct the luciferase reporter assay, T47D and HEK-293T
cells were cultured in 96-well plates at 4,000 cells/well. After an
overnight incubation, each well was treated with a transfection
mixture consisting of 150 ml of Opti-MEM (Invitrogen, Carlsbad,
CA, USA), 0.75 ml of Lipofectamine2000 (Invitrogen, Carlsbad,
CA, USA), 10 pmol of synthesized miRNA [negative control
(mirNC) or let-7 mimics (let-7a, c, d,o rf) (GenePharma, Shanghai,
China)] and 0.1 mg of psiCHECK2 vector (empty, psi-
CHECK2:rs3811463T, or psiCHECK2:rs3811463C). After a
five-hour incubation, medium in each well was replaced by
150 ml of serum-containing medium. After 48 h, the Renilla and
firefly luciferase activities were measured by the Dual-Luciferase
Reporter Assay (Promega, Madison, WI, USA) on a Veritas
Microplate Luminometer (Turner BioSystems, Sunnyvale, CA,
USA) according to the manufacturers’ protocol.
To determine whether the differential suppression of the
luciferase activities of psiCHECK2:rs3811463T and psi-
CHECK2:rs3811463C was let-7 dependent, similar luciferase
reporter assay was performed in T47D cells with mirNC and
different doses of synthesized let-7c (5 pmol–25 pmol) or let-7f
(10 pmol–20 pmol). The let-7 inhibiting assay was performed by
transfecting HEK-293T cells with a transfection mixture consist-
ing of 150 ml of Opti-MEM (Invitrogen, Carlsbad, CA, USA),
0.75 ml of Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA),
20 pmol of let-7 inhibitors [negative control (anti-mir-con) or anti-
let-7c plus anti-let-7d (10 pmol, respectively) (GenePharma, Shang-
hai, China)] and 0.1 mg of different psiCHECK2 vector (empty,
psiCHECK2:rs3811463T, or psiCHECK2:rs3811463C). The
remaining procedures were identical to those of the above-
mentioned luciferase assays.
Each experiment was performed at least three times in
triplicate. The luciferase score was calculated by normalizing the
luciferase signal of Renilla to that of firefly. Fold change (relative
luciferase activity) was reported by setting the scores of the control
groups as one and normalizing the scores in other groups.
Acquisition of normal breast tissue, real-time PCR, and
Western blot analyses
Normal breast tissue was donated by patients who had
undergone a mastectomy in the Department of Breast Surgery
after completing a written informed consent document. The fresh
breast tissue was obtained immediately after surgery, snap-frozen
in liquid nitrogen, and stored at 280uC. Careful dissection and
collection of normal epithelial cells from the fresh breast tissue was
achieved by employing laser-capture microdissection (Veritas
Automated Laser Microdissection System) as previously described
[33].
Total RNA was extracted from cultured cells or derivatives of
fresh breast tissue using TRIzol (Invitrogen, Carlsbad, CA, USA)
and cDNA was synthesized with the RevertAid First Strand cDNA
Synthesis Kit (Fermentas, Vilnius, Lithuania) according to the
manufacturers’ protocols. Real-time PCR evaluation of LIN28
mRNA was performed using the SYBR Green fluorescent-based
assay (Takara Bio, Shiga, Japan) in triplicate as previously
described [25]. GAPDH mRNA was used for normalization.
The small RNA was isolated and enriched using the mirVana
miRNA isolation kit (Ambion, Austin, TX). RNA (10 ng) was used
for synthesizing cDNA of let-7 and U6 control using the reverse
transcription (RT) primers (Applied Biosystems, Foster City, CA,
USA). The RT was performed with the TaqMan MicroRNA
Reverse Transcription Kit according to the manufacturer’s
protocol (Applied Biosystems, Foster City, CA, USA). Real-time
PCR was performed with corresponding TaqMan primers and
probes (Applied Biosystems, Foster City, CA, USA) in triplicate
using the Opticon Real-time PCR system (Bio-Rad MJ Research,
Waltham, MA, USA), according to the protocols provided by the
manufacturers.
Western blot was performed as previously described [25] using
an antibody against the human LIN28 protein (ab46020) (Abcam,
Hong Kong). GAPDH protein was used as the loading control.
The Western blot results were quantified with Quantity One (Bio-
Rad Laboratories, Hercules, CA USA).
Selection of SNPs in LIN28 for association studies
SNPs spanning a ,21.5-kb region from 2 kb upstream to 0.5 kb
downstream of the LIN28 gene were surveyed in the International
HapMap Project database (HapMap Data Rel 27 Phase II+III,
Feb 09, on NCBI B36 assembly). The International HapMap
Project had genotyped a large number of SNPs in different
populations and provided a set of tag SNPs (tSNPs) which could
efficiently represent evolutionally linked genetic variants [28].
Using the Tagger Pairwise method with an r
2 cutoff of 0.8 and
MAF cutoff of 0.05 in Han Chinese population, we selected five
tSNPs (rs12122703, rs3811464, rs1247955, rs3811463, and
rs6697410) which represent 68.8% (11/16) of the common SNPs
in the LIN28 gene. The five excluded SNPs were located within
the introns and they did not tag any other SNP. The selected
tSNPs can tag all the SNPs located in the promoter and 39 UTR of
LIN28. Two SNPs (rs12122703 and rs3811464) were located in
the 59 flanking region (promoter) of the LIN28 gene, another two
SNPs (rs3811463 and rs6697410) in the 39 UTR, and the
remaining SNP (rs11247955) was located in the intron (Figure
S2A).
Study populations and data collection for the
case-control studies
The relationship between the common SNPs of LIN28 and the
risk of breast cancer was investigated through two case-control
studies in a stepwise manner. All the participants were genetically
unrelated Han Chinese living in Shanghai City and its
surrounding areas. The first hospital-based case-control study
consisted of 1,004 patients with pathologically-confirmed primary
breast cancer and who were consecutively recruited from the
Department of Breast Surgery at Fudan University Shanghai
Cancer Center (FDUSHCC) between January 2004 and June
2008. During the same period, 1,296 controls, matched to the
cases by age and living regions, were enrolled from amongst
women who had come to the Outpatient Department of
FDUSHCC for breast cancer screening. In the validation study,
we recruited an additional 511 patients through the same process
between December 2008 and July 2009 and 645 control subjects
who were frequency matched to the cases by age. These control
subjects were from an on-going community-based breast cancer
screening program that has been previously described [25].
Participants with a previous history of cancer (except breast
cancer) and metastatic breast cancer were excluded from our
study. All the controls were determined as cancer-free after
comprehensive examinations.
Table S3 presents the detailed baseline characteristics of the
subjects enrolled in this study. After finishing a written informed
consent document, each participant was carefully interviewed to
obtain epidemiological information. Each participant donated
approximately 3–5 ml of peripheral venous blood, which was
collected in tubes with either EDTA or heparin anticoagulant.
This study was approved by the Ethics Committee of FDUSHCC.
All clinical investigations have been conducted according to the
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and controls in both the test set and the validation set were
comparable in age (mean age was 48.2 years for the cases and 48.5
years for the controls in the first set; mean age was 48.6 years for
the cases and 48.4 years for the controls in the validation set) and
menopausal status (proportion of postmenopausal women was
37.1% for the cases and 24.7% for the controls in the test set; the
proportion of postmenopausal women was 33.1% for the cases and
36.3% for the controls in the validation set). When compared with
the controls, the patients in both sets were younger at menarche,
and they had a higher body mass index (BMI) and fewer numbers
of children (P,0.05). Furthermore, a significant number of these
patients had a family history of first-degree relatives with breast
cancer. These differences partially reflected some of the risk factors
for breast cancer.
The clinicopathologic record of each patient was acquired via
the Patient Database of FDUSHCC. The status of estrogen
receptor (ER), progesterone receptor (PR), and human epidermal
growth factor receptor 2 (HER2) was determined among patients
with available data. The breast cancer IHC subtypes were defined
as previously described [34], only our classification was based on
the IHC results for the above mentioned three markers (ER, PR
and HER2), and we merged luminal A with luminal B as the
luminal subtype. Thus we defined breast cancer subtypes as:
luminal (ER+ and/or PR+), basal-like (ER2,P R 2, and HER22),
and HER2+/ER2 subtype (HER2+,E R 2,P R 2).
Genotyping
Genomic DNA was extracted from the blood leukocytes of the
participants using Gentra’s PureGene DNA Purification Kit
(Gentra systems, Minneapolis, MN, USA). Genotyping was done
mainly using the 12-plex SNPstream system (Beckman Coulter,
Fullerton, CA, USA) at the Chinese National Human Genome
Center at Shanghai. SNPs that could not be genotyped by this
platform due to the inability to design appropriate primers or
probes were genotyped by PCR and RFLP-based assays (Text S1,
Figure S2B and Table S4). To ensure the reliability of the results,
operators performing the genotyping assays were unaware of the
disease status of each sample, and each batch of samples contained
at least one positive control consisting of DNA samples with
known genotype and two negative controls of pure water. Two
researchers (K.D. Yu and A.X. Chen) independently examined the
gel pictures of the RFLP assays. The assays were redone if there
were inconsistencies regarding the results. Samples with disputable
outcomes in the second test were directly sequenced. Ten percent
of the samples were randomly selected for repeated RFLP assays,
and the results were 100% concordant.
Immunohistochemistry
The immunohistochemistry (IHC) assay was performed as
previously described [35] using an antibody specific for LIN28
(ab46020) (Abcam, Hong Kong). The results were scored based on
the percentage of tumor cells positively stained as follows: low
expression required less than 15% of positive cells, moderate
expression required 15–60% positive cells, and high expression
required greater than 60% positive cells.
Cell lines, LIN28 expression plasmid construct, and soft
agar assay
The cell lines (MDA-MB-231, MCF7, T47D, SK-BR-3, BT-
474, MCF 10A, and HEK 293T) were obtained from the
American Type Culture Collection (ATCC) and maintained in
complete growth medium as recommended by the distributor.
Liquid nitrogen stocks were made upon receipt, and they were
maintained until the start of each study. Morphology and doubling
times were also regularly recorded to ensure maintenance of
phenotypes. Cells were used for no more than 6 months after
being thawed.
The CDS of human LIN28 was cloned into the pCDH-CMV-
MCS-EF1-Puro expression vector (System Biosciences, Mountain
View, CA, USA) and confirmed by direct sequencing (primers
listed in Table S5). The empty or LIN28-CDS-fused pCDH
vectors were then packaged into VSV-G-pseudotyped viral
particles using the pPACKH1 Lentivector Packaging Kit (System
Biosciences, Mountain View, CA, USA) according to the
manufacturer’s protocol. The unconcentrated viral supernatant
was collected for infection.
MCF 10A cells stably transfected with LIN28 were acquired by
infecting approximately 50,000 MCF 10A cells with 1 ml of
unconcentrated viral supernatant, and they were selected in
medium containing 3 ng/ml puromycin. Soft agar assays were
performed as previously described [36]. Briefly, approximately
6,000 MCF 10A cells stably transfected with LIN28 or with empty
vector were cultured in soft agar media (Promega, Madison, WI,
USA) for three weeks before being stained with 0.05% crystal
violet and photographed. The colony number was counted using
Quantity One (Bio-Rad Laboratories, Hercules, CA USA).
Power analysis
The program Quanto (http://hydra.usc.edu/gxe) was used to
estimate the statistical power of our study. A dominant model was
adopted and a range of allelic frequencies, odds ratios, prevalence
of breast cancer observed in the studied population (25 in
100,000), and the sample size of 1,004 cases (accompanied by
1,296 controls) in the first case-control study were taken as the
parameters. For alleles with minor allele frequencies of 15%–20%,
our study has more than 95% power to detect alleles with ORs
higher than 1.4 and more than 81% power to detect those with
ORs of 1.3. The power drops for alleles with lower frequencies; for
those with 10% frequency, the power to identify effects higher
than 1.3 is 71%. When combining the two case-control studies
together, we have more than 99% power to detect alleles with
MAF higher than 15% and ORs of 1.4 and more than 93% power
for alleles with ORs of 1.3 and MAF higher than 15%.
Statistical analysis
HWE was tested by x
2 tests for each SNP locus. The
associations between alleles and breast cancer risk were deter-
mined by Pearson’s x
2 test, and the P-values were corrected using
the 1,000-time permutation test [37] or Bonferroni correction.
Logistic regression was used to analyze the associations between
genotypes and breast cancer risk. The crude OR and OR adjusted
for age, age at menarche, menopause status, number of birth, BMI
and family history of breast cancer (in first- and second-degree
relatives), along with 95% CI, were also determined. The
distribution of rs3811463 genotypes in patients with different
subtypes of breast cancer was analyzed by Pearson’s x
2 test.
Cochran-Mantel-Haenszel x
2 test was employed in association
tests involving ordered variables. Student’s t-test or Mann–
Whitney U test was employed to compare continuous variables
between two groups. One-way ANOVA or Kruskal–Wallis
analysis was used to compare continuous variables among three
or more groups. A P-value of no more than 0.05 was considered
statistically significant. Statistical analysis was performed using
Stata 10.0 (StataCorp, College Station, TX, USA) and SPSS
Software version 12.0 (SPSS Inc., Chicago, IL, USA). The
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using Haploview 4.2 and showed in Figure S2C [37].
Supporting Information
Figure S1 A, a schematic representation of the genomic
locations of common SNPs and the target sites of microRNAs
(miRNAs) in the 39 UTR of the human LIN28 gene. According to
the dbSNP database from National Center for Biotechnology
Information (NCBI) and the International HapMap Project
database, there are three SNPs with minor allele frequency
(MAF) higher than 5% among Han Chinese in the 39 UTR of the
human LIN28 gene (rs4659441, rs3811463, and rs6697410). The
SNPs and their locations, calculated from the start site of the 39
UTR of LIN28, are presented above the horizontal axis. The
target sites of miRNAs that might bind and regulate LIN28
according to TargetScanHuman (Release 5.1, http://www.
targetscan.org/) are shown below the horizontal axis. The
sequence, approximately 100-bp long and spanning from
approximately positions +900–+1000 of the 39 UTR of LIN28,
as well as the locations of the target sites of let-7 and rs3811463, are
shown in detail above the horizontal axis. Among all of the
predicted miRNA target sites, let-7 is nearest to rs3811463. B,
schematic representation of the luciferase reporter vectors. The
control psiCHECK2 luciferase vector (top) and psiCHECK2
vectors contain a partial LIN28 39 UTR sequence with either the
T (middle) or C (bottom) allele at the rs3811463 locus. C,
replication of the luciferase assay with increasing amounts of
synthesized let-7f. T47D cells were transfected with increasing
amounts of let-7f mimics, and the differential suppression of
psiCHECK2:rs3811463T and psiCHECK2:rs3811463C was ob-
served in a let-7f dose-dependent manner. D, real-time PCR
evaluation of the levels of let-7c and let-7d in HEK-293T cells
48 hours after transfection with anti-let-7c and anti-let-7d. Both
anti-let-7c and anti-let-7d could significantly suppress the level of
the corresponding mature let-7 family member.
(EPS)
Figure S2 A, candidate SNPs for genotyping. Five SNPs, spanning
the ,21.5-kb region from 2.0 kb upstream to 0.5 kb downstream of
LIN28 gene, were selected for genotyping. Of those, two SNPs are
located in the 59 promoter region, and one is located in the introns,
while the remaining two SNPs are located in the 39UTR of LIN28. B,
genotyping of rs3811464 and rs3811463 by PCR- and RFLP-based
assays. Above: Typical gel electrophoresis plots of the rs3811464G.A
polymorphism. The gel electrophoresis was performed on 2.5%
agarose gel at 120 V for 50 minutes. The main band from the
rs3811464-GGgenotype wasapproximately 170 bp in length,and the
main band from the rs3811464-AA genotype was approximately
270 bp in length, while the rs3811464-GA genotype has both bands.
Theoretically, there should be one more band of approximately
100 bp in length; however, this band was generally too weak to be
detected. Below: Typical gel electrophoresis plots of the rs3811463
T.C polymorphism. The gel electrophoresis was performed on 2.5%
agarose gel at 120 V for 40 minutes. The main band from the
rs3811463-TT genotype was approximately 536 bp, and the main
band from the rs3811463-CC genotype was approximately 379 bp.
The heterozygote, rs3811463-TC, has both bands. C, pairwise linkage
disequilibrium (LD) structure among selected SNPs in LIN28. Values
within the boxes: pairwise LD values measured as D9 (6100). Red-to-
white color gradient corresponds to higher to lower LD values; Solid
red boxes are perfect correlations (D9=1). The direction of LIN28
transcription is from left to right. The graph was modified from the
analysis results based on Haploview.
(EPS)
Table S1 Summary characteristics of the patients who donated
normal breast tissue.
(DOC)
Table S2 Distribution of rs3811463 genotype in different
subtypes of breast cancer.
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